Mutation of CD95 (Fas/Apo-1) gene in adult T-cell leukemia cells

Blood

Volumn 91, Issue 10, 1998, Pages 3935-3942

  Tamiya, Sadahiro ^b   Etoh, Ken Ichiro ^b   Suzushima, Hitoshi ^b   Takatsuki, Kiyoshi ^b   Matsuoka, Masao ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE DELETION; GENE INSERTION; HUMAN; HUMAN CELL; LEUKEMOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T CELL LEUKEMIA; T LYMPHOCYTE;

EID: 0032525107     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.10.3935.3935_3935_3942     Document Type: Article

References (48)

1. Takatsuki K, Uchiyama T, Sagawa K, Yodoi J: Adult T cell leukemia in Japan, in Seno S, Takaku F, Irino S (eds): Topics in Hematology. Proceedings of the 16th International Congress of Hematology. Amsterdam, The Netherlands, Excepta Medica, 1977, p 73
2. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H: Adult T-cell leukemia: Clinical and hematologic features of 16 cases. Blood 50:481, 1977
3. Poiesz BJ R F Gazdar AF, Bunn PA, Minna JD, Gallo RC: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77:7415, 1980
4. Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita K-I, Shirakawa S, Miyoshi I: Adult T-cell leukemia: Antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 78:6476, 1981
5. Yoshida M, Miyoshi I, Hinuma Y: Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 79:2031, 1982
6. Wang-Staal F, Gallo RC: Human T-lymphotropic retroviruses. Nature 317:395, 1985
7. Waldmann TA, Greene WC, Sarin PS, Saxinger C, Blayney DW, Blattner WA, Goldman CK, Bongiovanni K, Sharrow S, Depper JM, Leonard W, Uchiyama T, Gallo RC: Functional and phenotypic comparison of human T-cell leukemia/lymphoma virus positive adult T-cell leukemia with human T-cell leukemia/lymphoma virus negative Sezary leukemia, and their distinction using anti-Tac: Monoclonal antibody identifying the human receptor for T-cell growth factor. J Clin Invest 73:1711, 1984
8. Blattner WA, Gallo RC: Epidemiology of HTLV-I and HTLV-II infection, in Takatsuki K (ed): Adult T-Cell Leukemia. Oxford, UK, Oxford, 1994, p 45
9. Franchini, G. Molecular mechanisms of human T-cell leukemia/ lymphotropic virus type I infection. Blood 86:3619, 1995
10. Seiki M, Hikikoshi A, Taniguchi T, Yoshida M: Expression of the pX gene of HTLV-I: General splicing mechanism in the HTLV family. Science 228:1532, 1985
11. Yoshida M, Suzuki T: Regulation of HTLV-I gene expression and its roles in ATL development, in Takatsuki K (ed): Adult T-Cell Leukemia. Oxford, UK, Oxford, 1994, p 28
12. Franchini G, Mulloy JC, Koralnik IJ, Lo Monico A, Sparkowski JJ, Andresson T, Goldstein DJ, Schlegel R: The human T-cell leukemia/ lymphotropic virus type I p 121 protein cooperates with the E5 oncoprotein of bovine papillomavirus in cell transformation and binds the 16-kilodalton subunit of the vacuolar H+ATPase. J Virol 67:7701, 1993
13. Sodroski JG, Rosen CA, Haseltine WA: Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells. Science 225:381, 1984
14. Fujisawa J, Seiki M, Kiyokawa T, Yoshida M: Functional activation of the long terminal repeat of human T-cell leukemia virus type I by a trans-acting factor. Proc Natl Acad Sci USA 82:2277, 1985
15. Inoue J, Seiki M, Taniguchi T, Tsuru S, Yoshida M: Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type 1. EMBO J 5:2883, 1986
16. Watanabe T, Yamaguchi K, Takatsuki K, Osame M, Yoshida M: Constitutive expression of parathyroid hormone-related protein gene in human T cell leukemia virus type 1 (HTLV-1 ) carriers and adult T cell leukemia patients that can be trans-activated by HTLV-1 tax gene. J Exp Med 172:759, 1990
17. Sakurai H, Kondo N, lshiguro N, Mikuni C, Ikeda H, Wakisaka A, Yoshiki T: Molecular analysis of a HTLV-I pX defective human adult T-cell leukemia. Leuk Res 16:941, 1992
18. Tamiya S, Matsuoka M, Etoh K, Watanabe T, Kamihira S, Yamaguchi K, Takatsuki K: Two types of defective human T-lymphotropic virus type I (HTLV-I) provirus in adult T cell leukemia. Blood 88:3065, 1996
19. Knudson AG: Hereditary cancer, oncogenes and antioncogenes. Cancer Res 45:1437, 1985
20. Sakashita A, Hattori T, Miller CW, Suzushima H, Asou N, Takatsuki K, Koeffler HP: Mutations of the p53 gene in adult T cell leukemia. Blood 79:477, 1992
21. Hatta Y, Hirama T, Miller CW, Yamada Y, Tomonaga M, Koeffler HP: Holozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia. Blood 85:2699, 1995
22. Trauth BC, Klas C, Peters AMJ, Matzuku S, Moller P, Falk W, Debatin KM, Krammer PH: Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301, 1989
23. Yonehara S, Ishii A, Yonehara M: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the tumor necrosis factor. J Exp Med 169:1747, 1989
24. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233, 1991
25. Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the Fas ligand: A novel member of the tumor necrosis factor family. Cell 75:1169, 1993
26. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314, 1992
27. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S: Generalized lymphoproliferative diisease in mice, caused by a point mutation in the Fas gene. Cell 76:969, 1994
28. Nagata S, Golstein P: The Fas death factor. Science 267:1449, 1995
29. Nagata S: Apoptosis by death factor. Cell 88:355, 1997
30. Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middelton LA, Lin AY, Strober W, Leonard MJ, Puck JM: Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935, 1995
31. Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IA, Debatin KM, Fisher A, de Villarty JP: Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347, 1995
32. Dhein J, Walczak H, Baumler C, Debalin KM, Krammer PH: Autocrine T-cell suicide mediated by APO-1 (Fas/CD95). Nature 373:438, 1995
33. Matsuoka M, Matron T, Nishimura Y, Takatsuki K: ATL cells recognize self class II HLA antigens: Implication to leukemogenesis. Leukemia 9:1338, 1995
34. Shimoyama M, and Members of The Lymphoma Study Group: Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia-Iymphoma. Br J Haematol 79:428, 1991
35. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271, 1991
36. Debatin K-M, Goldman CK, Waldmann TA, Krammer PH: Apo-1-induced apoptosis of leukemia cells from patients with adult T-cell leukemia. Blood 81:2972, 1993
37. Friesen C, Herr I, Krammer PH, Debatin K-M: Involvement of the CD95 (Apo-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemic cells. Nat Med 2:574, 1996
38. Cheng J, Zhou T, Changdan L, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ, Mountz JD: Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263:1759, 1994
39. Fiucci G, Ruberti G: Detection of polymorphism the Fas cDNA sequence by GC-clamp denaturing gradient gel electrophoresis. Immunogenetics 39:437, 1994
40. Cascino I, Fiucci G, Papoff G, Ruberti G: Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J Immunol 154:2706, 1995
41. Kamihira S, Yamada Y, Hiragata Y, Yamaguchi T, Izumukawa K, Matsuo Y, Sugawara K, Tsuruta K, Atogami S, Tsukasaki K, Maeda T, Tomonaga M: Serum levels of soluble Fas/Apo-1 receptor in human retroviral infection and associated diseases. Intern Med 36:166, 1997
42. Xerri L, Carbuccia N, Pare P, Birg F: Search for rearrangements and/or allelic loss of the fas/APO-1 gene in 101 human lymphomas. Am J Clin Pathol 104:424, 1995
43. Landowski TH, Qu N, Buyuksal I, Painter JS, Dalton WS: Mutations in the Fas antigen in patients with mutiple myeloma. Blood 90:4266, 1997
44. Copeland KFT, Haaksma AGM, Goudsmit J, Krammer PH, Heeney JL: Inhibition of apoptosis in T cells expressing human T cell leukemia virus type I Tax. AIDS Res Hum Retroviruses 10:1259, 1994
45. Cai Z, Stancou R, Korner M, Chouaib S: Impairment of Fas-antigen expression in adriamycin-resistant but not TNF-resistant MCF7 tumor cells. Int J Cancer 68:535, 1996
46. Landowski TH, Gleason-Guzman MC, Dalton WS: Selection for drug resistance results in resistance to Fas-mediated apoptosis. Blood 89:1854, 1997
47. Eischen CM, Kottke TJ, Martins LM, Basi GS, Tung JS, Earnshaw WC, Leibson PJ, Kaufmann SH: Comaprison of apoptosis in wild-type and Fas-resistant cells: Chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions. Blood 90:935, 1997
48. Harada H, Kondo T, Ogawa S, Tamura T, Kitagawa M, Tanaka N, Lamphier MS, Hirai H, Taniguchi T: Acceralated exon skipping of IRF-1 mRNA in human myelodysplasia/leukemia: a possible mechanism of tumor suppressor inactivation. Oncogene 9:3313, 1994